Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Capital Reinvestment Ratio
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥837.18 Million) in capital expenditures (CN¥152.89 Million). See 301408 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Capital Reinvestment Ratio (2021–2025)
This chart tracks Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year Capital Reinvestment Ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. For live market cap and broader valuation context, see Anhui Huaren Health Pharmaceutical Co. L market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | CN¥837.18 Million | CN¥152.89 Million | ▼ -35.1% |
| 2024 | 0.28x | CN¥571.76 Million | CN¥160.89 Million | ▼ -82.9% |
| 2023 | 1.65x | CN¥131.37 Million | CN¥216.31 Million | ▲ +173.2% |
| 2022 | 0.60x | CN¥173.84 Million | CN¥104.77 Million | ▲ +150.3% |
| 2021 | 0.24x | CN¥140.82 Million | CN¥33.91 Million | — |